Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Mark‐David Levin, Johan A. Dobber et al.|Blood|2023Cited by 27
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working groupDoreen G. Te Raa, Michel van Gelder, Eduardus F. M. Posthuma et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 4